Journal of Glycobiology
Open Access

Role of High Mobility Group (HMG) Proteins in Glycobiology

Ritu Bhatt^{* *}Correspondence: Ritu Bhatt, Department of Biotechnology, Banaras Hindu University, Varanasi, India, Email:

Author info »

Description

High Mobility Group (HMG) proteins are a family of non-histone DNA-binding proteins that are present in all eukaryotic cells. These proteins are characterized by their ability to bind to DNA in a non-sequence-specific manner and to bend and twist DNA, which allows them to interact with other proteins and regulate gene expression.

HMG proteins are divided into three subfamilies, including HMGA, HMGB, and HMGN. Each subfamily has distinct functions and plays a crucial role in various cellular processes, such as transcription, replication, recombination and DNA repair.

HMGA proteins are architectural factors that bind to AT-rich regions of DNA and regulate the chromatin structure. These proteins are small and highly acidic, and their main function is to bend and twist DNA. HMGA proteins bind to DNA through their AT-hook domains, which recognize and bind to AT-rich regions of DNA.

In addition to their role in chromatin structure regulation, HMGA proteins have been implicated in various diseases, including cancer. Overexpression of HMGA proteins is commonly observed in many cancers and is associated with poor prognosis. HMGA proteins have been shown to promote tumorigenesis by regulating cell proliferation, apoptosis, and differentiation.

HMGB proteins are highly conserved and functionally diverse proteins that play a crucial role in DNA repair and immune response. These proteins are composed of three domains, including two positively charged DNA-binding domains and an acidic C-terminal tail.

HMGB proteins are involved in various DNA repair mechanisms, including base excision repair, nucleotide excision repair, and double-strand break repair. These proteins also play a critical role in the immune response by facilitating the recognition of damaged DNA by the innate immune system.

In addition to their role in DNA repair and immune response, HMGB proteins have been implicated in various diseases, including cancer and inflammatory disorders. HMGB proteins have been shown to promote tumorigenesis by regulating cell proliferation, apoptosis, and differentiation. Additionally, HMGB proteins have been implicated in inflammatory disorders such as rheumatoid arthritis, where they promote inflammation by activating immune cells.

HMGN proteins are chromatin-associated proteins that modulate gene expression by regulating chromatin structure and dynamics. These proteins are small and highly basic, and their main function is to bind to nucleosomes and regulate the accessibility of DNA to other proteins.

HMGN proteins are involved in various cellular processes, including transcriptional regulation, DNA repair and cell differentiation. These proteins have been shown to regulate gene expression by altering the chromatin structure and facilitating the recruitment of other transcriptional regulators.

In addition to their role in gene expression regulation, HMGN proteins have been implicated in various diseases, including cancer and neurodegenerative disorders. HMGN proteins have been shown to promote tumorigenesis by regulating cell proliferation, apoptosis, and differentiation. Additionally, HMGN proteins have been implicated in neurodegenerative disorders such as Alzheimer's disease, where they modulate the chromatin structure and regulate the expression of genes involved in neuronal function.

Conclusion

In summary, HMG proteins are a diverse family of DNA-binding proteins that play a critical role in regulating gene expression and other cellular processes. Each subfamily of HMG proteins has distinct functions and plays a crucial role in various cellular processes, such as transcription, replication, recombination, and DNA repair.

The dysregulation of HMG proteins has been implicated in various diseases, including cancer, inflammation, and neurodegenerative disorders. Therefore, understanding the function and regulation of HMG proteins is essential for the development of novel therapeutic strategies.

Currently, there are several approaches being explored to target HMG proteins for therapeutic purposes. These approaches include the development of small molecules that inhibit the DNA-binding activity.